Medical Innovation Exchange

Fresh from Pfizer deal, Roivant posts 'best-in-class' ulcerative colitis data on rival to Prometheus prospect

https://www.fiercebiotech.com/biotech/fresh-pfizer-deal-roivant-posts-best-class-ulcerative-colitis-data-and-stokes-prometheus

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!